Compounded medicine for wholely preventing and treating cardio-cerebral blood vessel diseases and use thereof

A compound technology for cardiovascular and cerebrovascular diseases, applied in the field of chemical drugs, can solve the problems of incompetent prevention and treatment of cardiovascular and cerebrovascular diseases, and achieve the effect of preventing cardiovascular and cerebrovascular events, preventing further occurrence, and protecting cardiovascular and cerebrovascular diseases

Inactive Publication Date: 2007-08-29
张士东
View PDF0 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because any single drug is not up to the task of preventing and treating complex cardiovascular and cerebrovascular diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0005] Example 1: The compound medicine consists of 0.5 mg of 17β estradiol, 0.3 mg of medroxyprogesterone, 2.5 mg of simvastatin, 2.0 mg of metoprolol, 0.5 mg of amlodipine, 200 mg of metformin, and 75 mg of aspirin Made into combination preparations, according to oral preparations (common tablets, dispersible tablets, film-coated tablets, sublingual tablets, orally disintegrating tablets, enteric-coated tablets, sustained-release tablets, immediate-release tablets, controlled-release tablets, hard capsules, enteric tablets, etc. Dissolving capsules, sustained-release capsules, etc.) preparation process is carried out. For early menopausal women. Control blood pressure, blood lipids, and blood sugar in an ideal state (blood pressure: 115 / 70mmHg; LDL_C: 1.0mmol / l; blood sugar: <6.0mmol / l). Control metabolic syndrome, monitor sex hormone levels.

Embodiment 2

[0006] Example 2: The compound medicine consists of 0.5 mg of 17β estradiol, 0.3 mg of medroxyprogesterone, 5 mg of simvastatin, 2.0 mg of metoprolol, 0.5 mg of amlodipine, 20 mg of acarbose, and aspirin 100mg made into combination preparations, according to oral preparations (common tablets, dispersible tablets, film-coated tablets, sublingual tablets, orally disintegrating tablets, enteric-coated tablets, sustained-release tablets, immediate-release tablets, controlled-release tablets, hard capsules, Enteric-coated capsules, sustained-release capsules, etc.) preparation process is carried out. For late menopausal women. Control blood pressure, blood lipids, and blood sugar in an ideal state (blood pressure: 115 / 70mmHg; LDL_C: 1.0mmol / l; blood sugar: <6.0mmol / l). Control metabolic syndrome, monitor sex hormone levels.

Embodiment 3

[0007] Embodiment 3: This compound medicine is made of soybean isoflavone 300mg and / or 17β estrogen 0.05mg, simvastatin 2.5mg, metoprolol 2.0mg, amlodipine 0.5mg, pioglitazone 10mg, aspirin 40mg Combination preparations, according to oral preparations (common tablets, dispersible tablets, film-coated tablets, sublingual tablets, orally disintegrating tablets, enteric-coated tablets, sustained-release tablets, immediate-release tablets, controlled-release tablets, hard capsules, enteric-coated tablets, etc. Capsules, sustained-release capsules, etc.) preparation process is carried out. For adult male high-risk groups. Control blood pressure, blood lipids, and blood sugar in an ideal state (blood pressure: 115 / 70mmHg; LDL_C: 1.0mmol / l; blood sugar: <6.0mmol / l). Control metabolic syndrome, monitor sex hormone levels.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a compound medicine for preventing and curing angiocardiopathy and cerebrovascular disease, belonging to the field of chemical medicine. It is characterized by that said compound medicine includes sexual hormones medicine, lipid-reducing medicine, hypotenser, hypoglycemic medicine and anticoagulant medicine. Said compound medicine can be made into various dosage forms. Besides, said compound medicine also can be used for curing the diseases of climacteric syndrome, osteoporosis, endometrial carcinoma, diabetes and metabolic syndrome, etc.

Description

technical field [0001] A compound medicine for comprehensive prevention and treatment of cardiovascular and cerebrovascular diseases. It belongs to the field of chemical medicine. Background technique [0002] In December 2005, we applied for the invention patent of "a compound drug for the prevention and treatment of cardiovascular and cerebrovascular diseases and its application", the patent application number: 2005102008329. Since then, a large number of new experimental evidences have shown that drug intervention or specific hypoglycemic drugs can delay the onset of diabetes and reduce the risk of cardiovascular and cerebrovascular diseases in high-risk patients with diabetes and patients with impaired glucose tolerance. Therefore, on the basis of the invention patent in 2005, we added hypoglycemic drugs, so that the new compound drug can truly prevent and treat cardiovascular and cerebrovascular diseases in an all-round way. It is expressed as follows: [0003] 1. Ca...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61K9/22A61K9/52A61K47/44A61P9/00
Inventor 吴立群
Owner 张士东
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap